Adap­tive Biotech­nolo­gies trims hand­ful of jobs as strate­gic re­view nears com­ple­tion

Adap­tive Biotech­nolo­gies, a Seat­tle-based di­ag­nos­tics mak­er and drug dis­cov­ery com­pa­ny, told End­points News it re­cent­ly elim­i­nat­ed 6.7% of its work­force as part of its strate­gic re­view.

The cuts were across “R&D, com­mer­cial, soft­ware, and op­er­a­tions func­tions,” the com­pa­ny said in an email. “We made strate­gic mod­i­fi­ca­tions to de­part­ment and team struc­tures that will al­low us to op­er­ate more ef­fec­tive­ly and ef­fi­cient­ly.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER